Victoria Rollason

2.0k total citations
50 papers, 1.3k citations indexed

About

Victoria Rollason is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Victoria Rollason has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 11 papers in Pediatrics, Perinatology and Child Health and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Victoria Rollason's work include Pharmacogenetics and Drug Metabolism (19 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Victoria Rollason is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Victoria Rollason collaborates with scholars based in Switzerland, United States and France. Victoria Rollason's co-authors include Jules Desmeules, Nicole P. Vogt, Caroline Samer, Youssef Daali, Kuntheavy Ing Lorenzini, Camille Lenoir, Pierre Dayer, Gürkan Kaya, Valérie Piguet and Helena Pontes and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Clinical Pharmacology & Therapeutics and Drugs.

In The Last Decade

Victoria Rollason

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victoria Rollason Switzerland 18 363 228 205 203 176 50 1.3k
Luisa Ibáñez Spain 21 264 0.7× 114 0.5× 189 0.9× 172 0.8× 248 1.4× 52 1.4k
Hitomi Teramachi Japan 16 231 0.6× 187 0.8× 119 0.6× 212 1.0× 161 0.9× 174 1.2k
Domenico Motola Italy 25 178 0.5× 157 0.7× 198 1.0× 125 0.6× 424 2.4× 87 1.7k
K.W. Woodhouse United Kingdom 13 342 0.9× 294 1.3× 196 1.0× 191 0.9× 96 0.5× 23 1.3k
Philip E. Empey United States 29 412 1.1× 101 0.4× 368 1.8× 137 0.7× 147 0.8× 98 2.0k
R. Lassalle France 22 139 0.4× 117 0.5× 141 0.7× 242 1.2× 146 0.8× 98 2.4k
Geneviève Durrieu France 24 192 0.5× 225 1.0× 320 1.6× 45 0.2× 247 1.4× 105 1.7k
Carmen Ferrajolo Italy 24 135 0.4× 87 0.4× 258 1.3× 143 0.7× 152 0.9× 56 1.4k
François Montastruc France 29 138 0.4× 302 1.3× 261 1.3× 112 0.6× 387 2.2× 145 2.3k
Agnès Sommet France 25 83 0.2× 153 0.7× 175 0.9× 100 0.5× 197 1.1× 123 2.0k

Countries citing papers authored by Victoria Rollason

Since Specialization
Citations

This map shows the geographic impact of Victoria Rollason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Rollason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Rollason more than expected).

Fields of papers citing papers by Victoria Rollason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Rollason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Rollason. The network helps show where Victoria Rollason may publish in the future.

Co-authorship network of co-authors of Victoria Rollason

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Rollason. A scholar is included among the top collaborators of Victoria Rollason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Rollason. Victoria Rollason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terrier, Jean, Pauline Gosselin, Camille Lenoir, et al.. (2025). Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban. British Journal of Clinical Pharmacology. 91(7). 2057–2069.
2.
Rodieux, Frédérique, Youssef Daali, Victoria Rollason, Caroline Samer, & Kuntheavy Ing Lorenzini. (2023). Practice of CYP450 genotyping and phenotyping in children in a real-life setting. Frontiers in Pharmacology. 14. 1130100–1130100. 2 indexed citations
3.
Terrier, Jean, Pauline Gosselin, Pierre Fontana, et al.. (2023). Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study. CPT Pharmacometrics & Systems Pharmacology. 12(10). 1541–1552. 5 indexed citations
4.
Mouterde, Médéric, Youssef Daali, Victoria Rollason, et al.. (2022). Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans. Genome Biology and Evolution. 14(12). 1 indexed citations
5.
Lenoir, Camille, Jean Terrier, Yvonne Gloor, et al.. (2022). Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. Journal of Personalized Medicine. 12(4). 526–526. 17 indexed citations
6.
Lenoir, Camille, et al.. (2021). Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics. CPT Pharmacometrics & Systems Pharmacology. 11(1). 30–43. 13 indexed citations
7.
Lenoir, Camille, Frédérique Rodieux, Jules Desmeules, Victoria Rollason, & Caroline Samer. (2021). Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review. Clinical Pharmacokinetics. 60(12). 1537–1555. 14 indexed citations
8.
Rollason, Victoria, Célia Lloret‐Linares, Kuntheavy Ing Lorenzini, et al.. (2020). Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study. Journal of Personalized Medicine. 10(4). 198–198. 9 indexed citations
9.
Lenoir, Camille, Youssef Daali, Victoria Rollason, et al.. (2020). Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail. Clinical Pharmacology & Therapeutics. 109(6). 1668–1676. 60 indexed citations
10.
Rollason, Victoria, Médéric Mouterde, Youssef Daali, et al.. (2020). Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins. Drug Safety. 43(11). 1181–1189. 12 indexed citations
11.
Rodieux, Frédérique, Kuntheavy Ing Lorenzini, & Victoria Rollason. (2019). [Importance and specificity of pharmacovigilance in the pediatric population].. PubMed. 15(645). 743–747. 1 indexed citations
12.
Lenoir, Camille, et al.. (2019). Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?. International Journal of Clinical Pharmacy. 41(6). 1634–1641. 16 indexed citations
13.
Kaya, Gürkan, et al.. (2015). Topical Corticosteroid-Induced Skin Atrophy: A Comprehensive Review. Drug Safety. 38(5). 493–509. 94 indexed citations
14.
Besson, Marie, Caroline Samer, Victoria Rollason, Pierre Dayer, & Jules Desmeules. (2015). Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements. Clinical Therapeutics. 37(7). 1588–1592. 1 indexed citations
15.
Girardin, François, Antoine Poncet, Marc Blondon, et al.. (2014). Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. The Lancet Psychiatry. 1(1). 55–62. 19 indexed citations
16.
Rollason, Victoria, Caroline Samer, Youssef Daali, & Jules Desmeules. (2014). Prediction by Pharmacogenetics of Safety and Efficacy of Non-Steroidal Anti- Inflammatory Drugs: A Review. Current Drug Metabolism. 15(3). 326–343. 37 indexed citations
17.
Pontes, Helena, et al.. (2014). Safety Signal Detection: The Relevance of Literature Review. Drug Safety. 37(7). 471–479. 40 indexed citations
18.
Rollason, Victoria, et al.. (2013). Role of P‐glycoprotein in the Uptake/Efflux Transport of Oral VitaminKAntagonists and Rivaroxaban through the Caco‐2 Cell Model. Basic & Clinical Pharmacology & Toxicology. 113(4). 259–265. 29 indexed citations
19.
Rollason, Victoria, Christian Lovis, Françoise Boehlen, et al.. (2012). Identification and weighting of the most critical “real-life” drug–drug interactions with acenocoumarol in a tertiary care hospital. European Journal of Clinical Pharmacology. 69(3). 617–627. 9 indexed citations
20.
Rollason, Victoria, et al.. (2012). CHALLENGES AND POTENTIAL SOLUTIONS FOR IMPLEMENTING RECENT COASTAL MANAGEMENT REFORMS. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Ibáñez Breakdown of academic impact, for papers by Hitomi Teramachi Breakdown of academic impact, for papers by Domenico Motola Breakdown of academic impact, for papers by K.W. Woodhouse Breakdown of academic impact, for papers by Philip E. Empey Breakdown of academic impact, for papers by R. Lassalle Breakdown of academic impact, for papers by Geneviève Durrieu Breakdown of academic impact, for papers by Carmen Ferrajolo Breakdown of academic impact, for papers by François Montastruc Breakdown of academic impact, for papers by Agnès Sommet
Rankless by CCL
2026